Medtronic plc Website

Medtronic plc

NYSE-MDT

Basic

  • Market Cap

    $104.13B

  • EV

    $122.35B

  • Shares Out

    1,282.27M

  • Revenue

    $32.36B

  • Employees

    95,000

Margins

  • Gross

    65.73%

  • EBITDA

    27.98%

  • Operating

    19.8%

  • Pre-Tax

    14.95%

  • Net

    11.36%

  • FCF

    16.07%

Returns (5Yr Avg)

  • ROA

    4.64%

  • ROTA

    12.66%

  • ROE

    8.3%

  • ROCE

    7.34%

  • ROIC

    7.25%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $93.24

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $8,005M

  • Net Debt

    $18.01B

  • Debt/Equity

    0.52

  • EBIT/Interest

    8.91

Growth (CAGR)

  • Rev 3Yr

    2.43%

  • Rev 5Yr

    1.16%

  • Rev 10Yr

    6.72%

  • Dil EPS 3Yr

    1.24%

  • Dil EPS 5Yr

    -4.14%

  • Dil EPS 10Yr

    -0.9%

  • Rev Fwd 2Yr

    4.03%

  • EBITDA Fwd 2Yr

    5.6%

  • EPS Fwd 2Yr

    5.75%

  • EPS LT Growth Est

    5.7%

Dividends

  • Yield

  • Payout

    99.69%

  • DPS

    $2.76

  • DPS Growth 3Yr

    5.96%

  • DPS Growth 5Yr

    6.65%

  • DPS Growth 10Yr

    9.44%

  • DPS Growth Fwd 2Yr

    0.75%

Select a metric from the list below to chart it

Apr '15

Apr '16

Apr '17

Apr '18

Apr '19

Apr '20

Apr '21

Apr '22

Apr '23

Apr '24

Apr '25 (E)

Apr '26 (E)

Apr '27 (E)

Total Revenues

28,913

30,117

31,686

31,227

32,364

Total Revenues % Chg.

-5.4%

4.2%

5.2%

-1.4%

3.6%

Cost of Goods Sold, Total

9,269

10,355

10,028

10,622

11,091

Gross Profit

19,644

19,762

21,658

20,605

21,273

Selling General & Admin Expenses, Total

9,882

9,956

10,047

10,004

10,183

R&D Expenses

2,331

2,493

2,746

2,696

2,735

Amortization of Goodwill and Intangible Assets

1,756

1,783

1,733

1,698

1,693

Other Operating Expenses

513

40

285

429

253

Other Operating Expenses, Total

14,482

14,272

14,811

14,827

14,864

Operating Income

5,162

5,490

6,847

5,778

6,409

Interest Expense, Total

-1,092

-925

-553

-583

-719

Interest And Investment Income

186

386

597

Net Interest Expenses

-1,092

-925

-367

-197

-122

Currency Exchange Gains (Loss)

477

-230

198

672

176

Other Non Operating Income (Expenses)

310

340

36

68

-293

EBT, Excl. Unusual Items

4,857

4,675

6,714

6,321

6,170

Restructuring Charges

-441

-617

-1,110

-645

-828

Merger & Related Restructuring Charges

-233

-338

Impairment of Goodwill

-61

Gain (Loss) On Sale Of Investments

-13

8

56

Gain (Loss) On Sale Of Assets

-75

Asset Writedown

-10

In Process R&D Expenses

-25

-45

Legal Settlements

-313

-118

-95

30

-149

Other Unusual Items

-29

-18

EBT, Incl. Unusual Items

4,055

3,895

5,517

5,364

4,837

Income Tax Expense

-751

265

456

1,580

1,133

Earnings From Continuing Operations

4,806

3,630

5,061

3,784

3,704

Minority Interest

-17

-24

-22

-26

-28

Net Income

4,789

3,606

5,039

3,758

3,676

Net Income to Common Incl Extra Items

4,789

3,606

5,039

3,758

3,676

Net Income to Common Excl. Extra Items

4,789

3,606

5,039

3,758

3,676

Total Shares Outstanding

1,341.1

1,345.4

1,330.7

1,330.8

1,311.3

Weighted Avg. Shares Outstanding

1,340.7

1,344.9

1,342.4

1,329.8

1,327.7

Weighted Avg. Shares Outstanding Dil

1,351.1

1,354

1,351.4

1,332.8

1,330.2

EPS

3.6

2.7

3.8

2.8

2.8

EPS Diluted

3.5

2.7

3.7

2.8

2.8

EBITDA

7,825

8,192

9,554

8,475

9,056

Effective Tax Rate

-18.5%

6.8%

8.3%

29.5%

23.4%